Mb. Grant et al., Proliferation, migration, and ERK activation in human retinal endothelial cells through A(2B) adenosine receptor stimulation, INV OPHTH V, 42(9), 2001, pp. 2068-2073
PURPOSE. The nucleoside adenosine has been implicated in angiogenesis. A pr
evious study demonstrated that activation of the A(2B) adenosine receptor (
AdoR) increases cAMP accumulation, cell proliferation, and VEGF expression
in human retinal endothelial cells (HRECs). In the present study, the role
of this receptor was further characterized by examination of the effects of
the selective A(2B) AdoR antagonists 3-N-propylxanthine (enprofylline) and
3-isobutyl-8-pyrrolidinoxanthine (IPDX) on AdoR-mediated HREC proliferatio
n, capillary tube formation, and signal-transduction pathways.
METHODS. HRECs were exposed to the adenosine analogue 5 ' -N-ethylcarboxami
do-adenosine (NECA) in the absence or presence of AdoR antagonists. Migrati
on was measured using Boyden chambers. Proliferation was assessed by counti
ng cells. Western analysis was used to assess extracellular signal-related
kinase (ERK) and cAMP response element-binding protein (CREB) in cell lysat
es. The effect of AdoR activation on tube formation was studied using cells
grown on a synthetic basement membrane matrix.
RESULTS. NECA induced proliferation in a concentration-dependent manner tha
t was inhibited by enprofylline and IPDX. NECA stimulated chemotaxis in a c
oncentration-dependent manner that was also blocked by both A(2B) AdoR anta
gonists. NECA activated ERK and CREB in HRECs. Both A(2B) AdoR antagonists
diminished activation of ERK by NECA exposure. ERK activation was also bloc
ked by the ERK-mitogen-activated protein kinase (MAPK) inhibitor PD98059, b
ut not by the protein kinase A (PKA) inhibitor H-89. CREB activation was bl
ocked by H-89, but not by PD98059, suggesting that ERK activation is indepe
ndent of PKA. NECA enhanced tube formation on the matrix, whereas both A(2B
) AdoR antagonists attenuated this effect.
CONCLUSIONS. The selective A(2B) AdoR antagonists, enprofylline and IPDX, i
nhibited NECA-stimulated proliferation, ERK activation, cell migration, and
capillary tube formation. A(2B) AdoR inhibition may offer a way to inhibit
retinal angiogenesis and provide a novel therapeutic approach to treatment
of diseases associated with aberrant neovascularization, such as diabetic
retinopathy and retinopathy of prematurity.